SUBSCRIBE: Print / Digital / eNewsletter
Rho kinase inhibitors—the newest drugs introduced for treating glaucoma—"get to the heart of the matter” by targeting specific glaucomatous abnormalities, such as trabecular meshwork outflow, said Yvonne Ou, MD.
A retrospective study concludes that surgical peripheral iridotomy (PI) has several advantages over laser treatment in some patients with uveitis.
This article was reviewed by Felipe Medeiros, MD, PhD
This article ws reviewed by Felipe A. Mediros, MD, PhD
This article was reviewed by Siamak Yousefi, PhD
This article was reviewed by Prof. Gus Gazzard, FRCOpthMA, MBBCHIR, MD
At Glaucoma 360 in San Francisco, Terri Pickering, MD, tolds attendees that artificial intelligence is a hot topic, with room to expand in the future.
At Glaucoma 360 in San Francisco, Terri Pickering, MD, tolds attendees that artificial intelligence is a hot topic, with room to expand in the future.
During the Glaucoma 360 annual meeting, Dake K. Heuer, MD, delivered the Shaffer-Hetherington-Hoskins Lecture Keynote address, titled “Risk Factors for Glaucoma Progression.”
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
